da Super User | Nov 27, 2020 | Eventi ATMP Forum
Webinar L’innovazione medica e tecnologica apportata dalle ATMP (Advanced Therapy Medicinal Products) offre nuove opzioni terapeutiche e di assistenza sanitaria per differenti patologie, tra cui malattie rare e particolarmente severe. L’attività di Horizon...
da Luca Bonadei | Ago 27, 2020 | Business
https://www.businesswire.com Triumvira Immunologics successfully completed a USD $55 million Series A financing round. The financing was co-led by Leaps by Bayer, the impact investment unit of Bayer AG, and Northpond Ventures. Triumvira’s foundational technology is...
da Luca Bonadei | Ago 27, 2020 | Business
https://www.businesswire.com Triumvira Immunologics ha completato con successo il finanziamento di Serie A da 55 milioni di dollari, condotto congiuntamente da Leaps di Bayer, l’unità di investimento di impatto di Bayer AG, e Northpond Ventures. La tecnologia...
da Luca Bonadei | Mag 27, 2020 | Other
https://www.pharmastar.it Presented during the Digital Week in Milan, WelCARe is a real “virtual ambulatory” based on the digital platform developed by Novartis, a pioneer in the development of CAR-T therapies, together with the Milan start-up Soluzioni...
da Luca Bonadei | Mar 27, 2020 | Business
https://ir.codexis.com Codexis, Inc., a leading protein engineering company and developer of novel biotherapeutics, announces the signing of a strategic collaboration and license agreement with Takeda Pharmaceutical Company Limited (Takeda) for the research and...
